James Leal - Nov 15, 2022 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
SVP, Operations
Signature
/s/ Shannon M. Hansen, Attorney-in-Fact for James A. Leal
Stock symbol
TNDM
Transactions as of
Nov 15, 2022
Transactions value $
-$3,170
Form type
4
Date filed
11/17/2022, 05:54 PM
Previous filing
Aug 31, 2022
Next filing
Nov 30, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $0 +167 +3.16% $0.00 5.46K Nov 15, 2022 Direct
transaction TNDM Common Stock Tax liability -$3.17K -75 -1.37% $42.27 5.38K Nov 15, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 +167 +11.07% $0.00 1.68K Nov 15, 2022 Common Stock 167 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
F2 Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").
F3 Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
F4 RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan.